Sustained Release Microspheres of Glipizide
Author Information
Author(s): Prasanna Phutane, Shidhaye S, Lotlikar V, Ghule A, Sutar S, Kadam V
Primary Institution: Bharati Vidyapeeth’s College of Pharmacy
Hypothesis
The objective of the current investigation is to reduce dosing frequency and improve patient compliance by designing and systematically evaluating sustained release microspheres of Glipizide.
Conclusion
The study successfully developed a sustained release formulation of Glipizide microspheres that can release the drug over approximately 12 hours, enhancing patient compliance.
Supporting Evidence
- The microspheres showed good flow properties and were spherical with smooth surfaces.
- Batch F3 had the highest drug encapsulation efficiency and sustained release for about 12 hours.
- The formulation was less complex and used cost-effective, biocompatible polymers.
Takeaway
Scientists made tiny balls that slowly release a diabetes medicine called Glipizide, so people don't have to take it as often.
Methodology
The microspheres were created using the emulsion solvent diffusion-evaporation method with ethyl cellulose and Eudragit® S100 as polymers.
Limitations
The study does not address the long-term effects of the sustained release microspheres in human subjects.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website